NCT01229618View on ClinicalTrials.gov

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

August 31, 2013

Conditions
Prostate Cancer
Interventions
DRUG

Hyperpolarized Pyruvate (13C) injection

single hyperpolarized pyruvate IV (intravenous) injection followed by MR imaging scans (MRI and MRSI)

Trial Locations (1)

94143

University of California San Francisco, San Francisco

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

University of California, San Francisco

OTHER